- Research
- Open access
- Published:
Hyperreflective material in patients with non-neovascular pachychoroid disease
BMC Ophthalmology volume 23, Article number: 255 (2023)
Abstract
Background
This study aimed to report eleven cases of non-neovascular pachychoroid disease with hyperreflective material (HRM) that occurred in Japanese patients.
Methods
A retrospective review of data from eleven patients who had non-neovascular retinal pigment epithelium (RPE) protrusion with HRM in the neurosensory retina between March 2017 and June 2022 was conducted. Clinical examination, color fundus photography, fluorescein angiography, spectral-domain optical coherence tomography (SD-OCT), and OCT angiography data were analyzed. Main outcome measures were patient characteristics, changes in SD-OCT findings, and symptom outcomes.
Results
All cases had RPE protrusion and HRM with dilated choroidal veins, which were characteristic of pachychoroid disease. However, none of the cases had macular neovascularization (MNV). In 9 eyes (81.8%), HRM improved spontaneously without intervention and resulted in alterations in RPE, referred to as pachychoroid pigment epitheliopathy (PPE) or focal choroidal excavation (FCE). In these cases, symptoms such as metamorphopsia and distortion improved without treatment. In the remaining two cases (18.2%), HRM still persisted during the follow-up period.
Conclusion
There are some cases of non-neovascular pachychoroid disorder with HRM, which might be a new entity of pachychoroid spectrum disease or an early stage of PPE or FCE. These cases should not be misdiagnosed as MNV, and careful observation is necessary.
Background
The development of optical coherence tomography (OCT) [1] and OCT angiography (OCTA) [2], which are novel noninvasive multimodal imaging modalities, has enabled the evaluation of the choroidal structure and morphology in patients with various chorioretinal diseases. Using these modalities, pachychoroid spectrum diseases, characterized by thick choroid, pachyvessels, attenuation of the inner choroid, and choroidal vascular hyperpermeability on indocyanine green angiography (ICGA), have been recently described [3]. Pachychoroid neovasculopathy [4] and polypoidal choroidal vasculopathy [5] are included in the pachychoroid-related spectrum of diseases associated with type 1 macular neovascularization (MNV). Furthermore, pachychoroid pigment epitheliopathy (PPE) [6], focal choroidal excavation (FCE) [7] and central serous chorioretinopathy (CSC) [8] also reside within the category of pachychoroid-related diseases with non-neovascular lesions. However, previous cases associated with non-neovascular pahychoroid disease showed no hyperreflective material (HRM) in the neurosensory retina.
Warrow et al. reported that PPE should be suspected in eyes with choroidal thickening and associated abnormalities of the retinal pigment epithelium (RPE) with neither history of subretinal fluid (SRF) nor type 1 MNV [6]. On the other hand, Jampol et al. firstly described that FCE is characterized by an unusual concavity in the choroid without staphyloma or scleral ectasia [9] and occurs in combined with other macular diseases such as CSC or MNV [10]. However, all cases reported in their articles had no HRM in the neurosensory retina. Recently, our group experienced cases of non-neovascular pachychoroid disease with HRM among relatively young Japanese patients, which finally resulted in PPE or FCE after the resolution of HRM. The purpose of this study is to put together these cases that describe that entity and provides a natural history for the HRM.
Methods
We conducted a retrospective review of the data of patients who had non-neovascular pachychoroid lesions with HRM in the neurosensory retina between March 2017 and June 2022. We studied eleven eyes of eleven patients in an observational case series. The patients were seen at Yokohama City University Medical Center after undergoing a prior evaluation by outside ophthalmologists, or were diagnosed by retina specialists (M.M. and Y.Y.) in a private clinic for metamorphopsia or visual complaints. This study design was approved by the institutional review board at Yokohama City University Medical Center and followed the tenets of the Declaration of Helsinki.
Inclusion criteria were the presence of non-neovascular pachychoroid lesions with HRM in the neurosensory retina determined by clinical findings and multimodal imaging. HRM were defined as hyper- or isoreflective exudation by using spectral-domain OCT (SD-OCT, SPECTRALIS OCT2 Multicolor version 6.12; Heidelberg Engineering Inc., Dossenheim, Germany and RS-3000 Advance; Nidek Co., Ltd., Aichi, Japan). SD-OCT system with built-in eye-tracking can provide reproducible measurements and we were able to evaluate the same location on OCT images at different time point [11]. Fluorescein angiography (FA), ICGA (SPECTRALIS Product Family version 5.3; Heidelberg Engineering, Inc.), fundus autofluorescence (FAF; Optos California®, Optos PLC, Dunfermline, UK), and OCTA (DRI OCT Triton; Topcon Corporation, Tokyo, Japan) were also used to evaluate the HRM lesions.
Central choroidal thickness (CCT) was measured in all eyes and was defined as the maximum thickness between the Bruch’s membrane and the inner surface of the choroidal–scleral junction at the fovea. Manual digital calipers were used to acquire these measurements. These cases were collected via a chart review, and data from these patients were reviewed. Changes in SD-OCT findings, changes of best-collected visual acuity (BCVA), and outcomes of the patients’ symptoms were investigated. Comparison of BCVA and CCT between baseline and last visit was performed using the Wilcoxon signed-rank test.
Results
We included a total of eleven eyes from eleven patients in this study. Table 1 shows the demographic and clinical characteristics of patients of non-neovascular pachychoroid disease with HRM in the neurosensory retina. Two of the eleven patients were given a diagnosis of idiopathic choroidal neovascularization (ICNV) or age-related macular degeneration (AMD) from their previous ophthalmologists, and two patients were referred for RPE changes in the macula. Of the eleven patients, eight (72.7%) were men and three (27.3%) were women. The mean patient age was 40.8 ± 10.7 years (median, 43 years; range, 23–60 years). The mean CCT was 307 ± 62 μm (range, 227–440 μm). All eleven eyes demonstrated pathologically dilated choroidal vessels (pachyvessels) on SD-OCT. The mean logarithm of the minimum angle of resolution (logMAR) BCVA was 0.062 (Snellen 20/23, range; 20/40 − 20/16). Representative cases of the patients are shown in Figs. 1, 2, 3, 4 and 5, respectively.
Changes in SD-OCT findings
Of these 11 eyes, HRM at the subretinal space were present in 10 eyes (90.9%). There was presence of HRM at the outer nuclear layer (ONL) in 6 eyes (54.5%) and at the outer plexiform layer (OPL) in 4 eyes (36.4%). Among these 11 patients, 4 eyes (36.4%) had acoustic hyperreflectivity behind the HRM. In nine patients (81.8%), HRM improved spontaneously without intervention such as anti-vascular endothelial growth factor (VEGF) or anti-inflammatory therapy within 1 year. Four of nine (44.4%) eyes resulted in RPE alterations, which is referred to as PPE. Furthermore, three of nine eyes (33.3%) showed focal choroidal excavation (FCE) after the improvement of HRM. On the other hand, HRM persisted during the follow-up period in the remaining two eyes (18.2%). The mean CCT in last visit was 305 ± 47 μm, which was no significant difference compared with baseline (p = 0.929).
Symptom outcomes
The mean log MAR BCVA significantly improved from 0.062 to -0.001 (Snellen 20/19) (p = 0.046). Symptoms such as metamorphopsia or distortion also improved in nine eyes (81.8%) where the HRM ameliorated. On the other hand, the remaining two eyes (18.2%) with persistence of HRM showed no improvement of their symptoms.
Discussion
Our observational case series demonstrated that there are some cases of non-neovascular disease with HRM. All cases had thickened choroids and pachyvessels at a relatively young age. Furthermore, HRM improved spontaneously without intervention in nine eyes (81.8%) and finally resulted in so-called PPE or FCE. Although these cases are very rare in a real-world clinical setting, it could be a new entity of pachychoroid spectrum disease or an early stage of PPE or FCE. In addition, these cases might be misdiagnosed as AMD or ICNV because of the existence of HRM and suspected MNV. However, it is important that these cases should be diagnosed as non-neovascular disease using multimodal imaging and carefully observed without any intervention. To our knowledge, non-neovascular pachychoroid disorder with HRM reported in this study has not previously been described.
In the previous studies, HRM at the subretinal space were reported as subretinal hyperreflective material (SHRM). In the Comparison of Age-Related Macular degeneration Treatments Trials (CATT), SHRM was an important morphologic biomarker for worse visual acuity in patients with AMD [12]. SHRM is known to have several components, such as neovascular tissue, fibrosis, hemorrhage, and exudation, likely comprising serum, fibrin, and inflammatory cells [13,14,15]. However, in our cases, it is deniable that HRM consists of neovascular tissue, fibrosis, or hemorrhage based on fundoscopic findings or multimodal imaging. Therefore, in this study, it is highly possible that HRM components were some kind of exudation. A previous study reported that in patients with CSC, which is categorized as one type of pachychoroid spectrum disease, breaches in the RPE could allow a large molecule, such as fibrin, to enter from the sub-RPE into the subretinal spaces [16]. Although the reason why patients in our study demonstrated HRM is uncertain, damage to the choriocapillaris, which was caused by the pachyvessels [17], would allow a large molecule such as fibrin to escape into the sub-RPE space. Furthermore, damage to the RPE would allow this molecule to enter from the sub-RPE to the subretinal spaces or neurosensory retina.
In our study, HRM were seen not only at the subretinal space but also at the OPL and ONL. Previous studies described that hyperreflective foci (HRF) [18], which is defined as hyperreflective speckling in the neurosensory retina detected by using SD-OCT, have been identified in various chorioretinal diseases [19,20,21]. In this study, 4 eyes (case 1, 4, 5, and 6) had HRF, and these cases had acoustic hyperreflectivity behind the HRM. Proposed origin of HRF have several hypotheses, such as displacing RPE cells [18], activated microglia cells [22], and lipid extravasation [23]. Therefore, in some cases of this study, HRM might consist of these components.
In nine cases (81.8%), HRM improved spontaneously and four of them resulted in so-called PPE and three of them showed FCE. Symptoms such as metamorphopsia or distortion also improved in these eyes where the HRM ameliorated. Because both PPE and FCE are usually asymptomatic, we speculate that HRM was the cause of their symptoms. A previous study reported the morphologic characteristics of patients with CSC evaluated by SD-OCT [24]. Those authors described that SRF with subfoveal fibrin was more commonly observed in the early period of acute CSC than in eyes with chronic CSC. We speculate that having HRM indicates an active stage, and these characteristics disappear spontaneously when the activity declines. In addition, RPE alterations occur after improvement of HRM. Monés et al. described that some patients with soft drusen due to AMD showed isoreflective dots at the outer retinal layers associated with RPE defects. They have termed this ‘drusen ooze’, which was associated with a high risk of developing atrophy [25]. They hypothesized that drusen ooze could activate the surface of RPE, resulting in an increase in phagocytosis of extracellular debris that exceeds the RPE capacity, and finally leads to RPE death. Morphologic characteristics in our study are similar to that of their study. Therefore, HRM may activate the RPE apical surfaces, phagocytosed by RPE cells, and finally morphologic features might be similar to PPE.
Furthermore, three eyes (27.3%) showed FCE after the resolution of HRM. Although the pathogenesis of FCE formation is still uncertain, previous reports described that FCE lesions are congenital choroidal abnormalities [9, 26]. On the other hand, some reports mentioned that FCE may occur in associated with inflammatory diseases such as multiple evanescent white dot syndrome, multifocal choroiditis, or Vogt–Koyanagi–Harada disease [27,28,29]. Similar to these cases, HRM in the neurosensory retina, due to inflammatory process, could be a mechanism leading to FCE formation. However, all cases in our study didn’t need anti-inflammatory therapy and improved spontaneously. Inflammation caused by HRM may be weak enough not to require treatment. Otherwise, it is a self-limited disorder.
In this study, the differential diagnosis was neovascular diseases, such as ICNV and AMD, because SHRM, which is derived from exudation, is generally associated with active MNV and often regresses as the MNV becomes quiescent after anti-VEGF treatment [14, 30]. However, all cases in this study had no MNV by multimodal imaging and were finally observed carefully without any intervention. Because the current optimal treatment for either ICNV or AMD is anti-VEGF agents [31, 32], it is important to check the existence of MNV by multimodal imaging and differentiate non-neovascular lesions with HRM from ICNV or AMD.
There are also some cases of non-neovascular pachychoroid lesion with HRM, which have SRF, as shown in Fig. 6. We speculate that the pathological mechanism of these cases are similar to our cases without SRF. However, these cases are now generally categorized as CSC due to SRF and photodynamic therapy might be taken into consideration for treatment [33].
The limitations of this study are the small sample size and its retrospective nature. Although these cases are very rare in the clinical setting, larger numbers of study subjects with detailed analysis are needed in the future. In addition, the evaluation of multimodal imaging could be reader dependent; to minimize this confounding factor, an AI machine system that includes machine-learning algorithms should be investigated. This could enable earlier detection of non-neovascular pachychoroid diseases and demonstrate there is no need for treatment.
Conclusions
We experienced eleven cases that had non-neovascular pachychoroid diseases with HRM. In addition, it is important to avoid a misdiagnosis of ICNV or AMD. It should be noted that non-neovascular pachychoroid diseases with HRM, occurring in relatively young adults, improve spontaneously without intervention.
Availability of data and materials
The datasets used during the current study are available from the corresponding author on reasonable request.
Abbreviations
- OCT:
-
Optical coherence tomography
- OCTA:
-
OCT angiography
- ICGA:
-
Indocyanine green angiography
- MNV:
-
Macular neovascularization
- PPE:
-
Pachychoroid pigment epitheliopathy
- FCE:
-
Focal choroidal excavation
- CSC:
-
Central serous chorioretinopathy
- HRM:
-
Hyperreflective material
- RPE:
-
Retinal pigment epithelium
- SRF:
-
Subretinal fluid
- SD-OCT:
-
Spectral-domain OCT
- FA:
-
Fluorescein angiography
- FAF:
-
Fundus autofluorescence
- CCT:
-
Central choroidal thickness
- BCVA:
-
Best-corrected visual acuity
- ICNV:
-
Idiopathic choroidal neovascularization
- AMD:
-
Age-related macular degeneration
- Log MAR:
-
Logarithm of the minimum angle of resolution
- ONL:
-
Outer nuclear layer
- OPL:
-
Outer plexiform layer
- VEGF:
-
Vascular endothelial growth factor
- SHRM:
-
Subretinal hyperreflective material
- HRF:
-
Hyperreflective foci
References
Spaide RF, Koizumi H, Pozzoni MC. Enhanced depth imaging spectral-domain optical coherence tomography. Am J Ophthalmol. 2008;146(4):496–500.
Spaide RF, Klancnik JM Jr, Cooney MJ. Retinal vascular layers imaged by fluorescein angiography and optical coherence tomography angiography. JAMA Ophthalmol. 2015;133(1):45–50.
Cheung CMG, Lee WK, Koizumi H, Dansingani K, Lai TYY, Freund KB. Pachychoroid disease. Eye (Lond). 2019;33(1):14–33.
Pang CE, Freund KB. Pachychoroid neovasculopathy. Retina. 2015;35(1):1–9.
Balaratnasingam C, Lee WK, Koizumi H, Dansingani K, Inoue M, Freund KB. Polypoidal Choroidal Vasculopathy: a distinct disease or manifestation of many? Retina. 2016;36(1):1–8.
Warrow DJ, Hoang QV, Freund KB. Pachychoroid pigment epitheliopathy. Retina. 2013;33(8):1659–72.
Chung H, Byeon SH, Freund KB, Focal choroidal excavation and its association with pachychoroid spectrum disorders. A review of the literature and Multimodal Imaging Findings. Retina. 2017;37(2):199–221.
Fung AT, Yannuzzi LA, Freund KB. Type 1 (sub-retinal pigment epithelial) neovascularization in central serous chorioretinopathy masquerading as neovascular age-related macular degeneration. Retina. 2012;32(9):1829–37.
Jampol LM, Shankle J, Schroeder R, Tornambe P, Spaide RF, Hee MR. Diagnostic and therapeutic challenges. Retina. 2006;26(9):1072–6.
Obata R, Takahashi H, Ueta T, Yuda K, Kure K, Yanagi Y. Tomographic and angiographic characteristics of eyes with macular focal choroidal excavation. Retina. 2013;33(6):1201–10.
Menke MN, Dabov S, Knecht P, Sturm V. Reproducibility of retinal thickness measurements in healthy subjects using spectralis optical coherence tomography. Am J Ophthalmol. 2009;147(3):467–72.
Willoughby AS, Ying GS, Toth CA, Maguire MG, Burns RE, Grunwald JE, Daniel E, Jaffe GJ. Comparison of age-related Macular Degeneration treatments trials Research G: Subretinal Hyperreflective Material in the comparison of age-related Macular Degeneration treatments trials. Ophthalmology. 2015;122(9):1846–1853e1845.
Ristau T, Keane PA, Walsh AC, Engin A, Mokwa N, Kirchhof B, Sadda SR, Liakopoulos S. Relationship between visual acuity and spectral domain optical coherence tomography retinal parameters in neovascular age-related macular degeneration. Ophthalmologica. 2014;231(1):37–44.
Ores R, Puche N, Querques G, Blanco-Garavito R, Merle B, Coscas G, Oubraham H, Semoun O, Souied EH. Gray hyper-reflective subretinal exudative lesions in exudative age-related macular degeneration. Am J Ophthalmol. 2014;158(2):354–61.
Spaide RF, Jaffe GJ, Sarraf D, Freund KB, Sadda SR, Staurenghi G, Waheed NK, Chakravarthy U, Rosenfeld PJ, Holz FG, et al. Consensus nomenclature for reporting neovascular age-related Macular Degeneration Data: Consensus on Neovascular Age-Related Macular Degeneration nomenclature Study Group. Ophthalmology. 2020;127(5):616–36.
Rajesh B, Kaur A, Giridhar A, Gopalakrishnan M. Vacuole” sign adjacent to retinal pigment epithelial defects on Spectral Domain Optical Coherence Tomography in Central Serous Chorioretinopathy Associated with Subretinal Fibrin. Retina. 2017;37(2):316–24.
Baek J, Kook L, Lee WK. Choriocapillaris Flow Impairments in Association with Pachyvessel in Early Stages of Pachychoroid. Sci Rep. 2019;9(1):5565.
Schuman SG, Koreishi AF, Farsiu S, Jung SH, Izatt JA, Toth CA. Photoreceptor layer thinning over drusen in eyes with age-related macular degeneration imaged in vivo with spectral-domain optical coherence tomography. Ophthalmology. 2009;116(3):488–496e482.
Deak GG, Bolz M, Kriechbaum K, Prager S, Mylonas G, Scholda C, Schmidt-Erfurth U, Diabetic Retinopathy Research Group V. Effect of retinal photocoagulation on intraretinal lipid exudates in diabetic macular edema documented by optical coherence tomography. Ophthalmology. 2010;117(4):773–9.
Akagi-Kurashige Y, Tsujikawa A, Oishi A, Ooto S, Yamashiro K, Tamura H, Nakata I, Ueda-Arakawa N, Yoshimura N. Relationship between retinal morphological findings and visual function in age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol. 2012;250(8):1129–36.
Ogino K, Murakami T, Tsujikawa A, Miyamoto K, Sakamoto A, Ota M, Yoshimura N. Characteristics of optical coherence tomographic hyperreflective foci in retinal vein occlusion. Retina. 2012;32(1):77–85.
Coscas G, De Benedetto U, Coscas F, Li Calzi CI, Vismara S, Roudot-Thoraval F, Bandello F, Souied E. Hyperreflective dots: a new spectral-domain optical coherence tomography entity for follow-up and prognosis in exudative age-related macular degeneration. Ophthalmologica. 2013;229(1):32–7.
Bolz M, Schmidt-Erfurth U, Deak G, Mylonas G, Kriechbaum K, Scholda C, Diabetic Retinopathy Research Group V. Optical coherence tomographic hyperreflective foci: a morphologic sign of lipid extravasation in diabetic macular edema. Ophthalmology. 2009;116(5):914–20.
Song IS, Shin YU, Lee BR. Time-periodic characteristics in the morphology of idiopathic central serous chorioretinopathy evaluated by volume scan using spectral-domain optical coherence tomography. Am J Ophthalmol. 2012;154(2):366–375e364.
Mones J, Garcia M, Biarnes M, Lakkaraju A, Ferraro L. Drusen Ooze: a Novel Hypothesis in Geographic Atrophy. Ophthalmol Retina. 2017;1(6):461–73.
Margolis R, Mukkamala SK, Jampol LM, Spaide RF, Ober MD, Sorenson JA, Gentile RC, Miller JA, Sherman J, Freund KB. The expanded spectrum of focal choroidal excavation. Arch Ophthalmol. 2011;129(10):1320–5.
Hashimoto Y, Saito W, Noda K, Ishida S. Acquired focal choroidal excavation associated with multiple evanescent white dot syndrome: observations at onset and a pathogenic hypothesis. BMC Ophthalmol. 2014;14:135.
Kim H, Woo SJ, Kim YK, Lee SC, Lee CS. Focal Choroidal Excavation in Multifocal Choroiditis and Punctate Inner Choroidopathy. Ophthalmology. 2015;122(7):1534–5.
Nishikawa Y, Fujinami K, Watanabe K, Noda T, Tsunoda K, Akiyama K. Clinical course of focal choroidal excavation in Vogt-Koyanagi-Harada disease. Clin Ophthalmol. 2014;8:2461–5.
Shah VP, Shah SA, Mrejen S, Freund KB. Subretinal hyperreflective exudation associated with neovascular age-related macular degeneration. Retina. 2014;34(7):1281–8.
Inoue M, Kadonosono K, Watanabe Y, Sato S, Kobayashi S, Yamane S, Ito R, Arakawa A. Results of 1-year follow-up examinations after intravitreal bevacizumab administration for idiopathic choroidal neovascularization. Retina. 2010;30(5):733–8.
Rosenfeld PJ, Brown DM, Heier JS, Boyer DS, Kaiser PK, Chung CY, Kim RY, Group MS. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med. 2006;355(14):1419–31.
Yannuzzi LA, Slakter JS, Gross NE, Spaide RF, Costa D, Huang SJ, Klancnik JM Jr, Aizman A. Indocyanine green angiography-guided photodynamic therapy for treatment of chronic central serous chorioretinopathy: a pilot study. Retina. 2003;23(3):288–98.
Acknowledgements
None.
Funding
None.
Author information
Authors and Affiliations
Contributions
MM and YY were involved in data collection. MM, YY, and TI were involved in data analyses. MM, YY, and SM were involved in writing of the manuscript. YY, SM, YK, SI, TI and KK were involved in critical revision the manuscript. MM and YY were involved in design of the study.
Corresponding author
Ethics declarations
Ethics approval and consent to participate
The study was approved by the ethics committee of the Yokohama City University, Japan (approval number: F210900030) and written informed consent was obtained from all patients enrolled in this study.
Consent for publication
Written informed consent was obtained. That is, the patient provided written, retrospective consent for publication following detailed explanation of the purpose of the manuscript and understanding that no identifiable information was going to be released.
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Maruyama-Inoue, M., Yanagi, Y., Mohamed, S. et al. Hyperreflective material in patients with non-neovascular pachychoroid disease. BMC Ophthalmol 23, 255 (2023). https://doi.org/10.1186/s12886-023-03011-2
Received:
Accepted:
Published:
DOI: https://doi.org/10.1186/s12886-023-03011-2